A popular cannabis-derived epilepsy treatment is increasing sales for a London company making pharmaceutical treatments from marijuana. London-based GW Pharmaceuticals told investors Monday that it rang up $108 million in sales last quarter and $309 million for calendar 2019. The company’s fourth-quarter sales beat consensus analyst expectations of $102.4 million. GW attributed the sales figures to physicians […]
Read More
EMAIL: [email protected]
PHONE: 720.643.4450
PHONE: 720.643.4450
USDA announces long-delayed hemp rules, calls for total THC testing
The U.S. Department of Agriculture (USDA) released a nationwide proposal for growing hemp and testing its THC content, a move that comes more than 10 months after the U.S. Congress legalized hemp and ordered the USDA to regulate it.
Read More
Linton back in cannabis business as chair, investor and adviser
Ousted Canopy Growth co-CEO Bruce Linton is getting back into the marijuana business in a big way, resurfacing as a senior executive, investor and adviser in three separate companies in the U.S. and Canada. Linton is joining Michigan-based Gage Cannabis Co. as executive chair, parent company Wolverine Partners said Tuesday. Gage said in a news […]
Read More
Anti-cannabis governor targets hemp, saying plant too close for police
A Republican governor who strongly opposes cannabis legalization says that allowing hemp cultivation is just as problematic. South Dakota Gov. Kristi Noem took her argument national in The Wall Street Journal, arguing in an op-ed column that law enforcement doesn’t have the testing capacity to discern between marijuana and legal hemp, which has no more […]
Read More
‘Pent-up demand’ for FDA-approved cannabis drug boosts UK maker
Strong patient interest in the only federally approved CBD product in the United States helped drugmaker GW Pharmaceuticals record $72 million in revenue last quarter. Epidiolex, which is made by London’s GW Pharma (Nasdaq: GWPH), is a seizure control drug approved by the U.S. Food and Drug Administration. It has seen brisk sales and new patient enrollments since the […]
Read More
Cannabis waste disposal is becoming big business as firms look to monetize marijuana, hemp biomass
Marijuana waste gives entrepreneurs an opportunity to enter an emerging cannabis sector that turns plant refuse and post-extraction leftovers into marketable products that range from animal bedding to construction materials.
Read More
Texas mulls a broadened limited medical marijuana program
Texas is looking at dramatically expanding its limited medical cannabis program to allow patients with a range of new medical conditions, from post-traumatic stress disorder to cancer, to qualify for marijuana-derived oils high in CBD. A bill was approved 7-1 by the House Committee on Public Health and is awaiting a vote in the Texas […]
Read More
Georgia lifts ban on commercial medical marijuana production
Georgia Gov. Brian Kemp has opened the state to commercial medical cannabis cultivation, signing a bill to create new business opportunities in the Peach State’s limited MMJ program. The measure outlines the first opportunities for private businesses to grow and sell cannabis. Georgia launched its limited MMJ program in 2015, though the cultivation, manufacture or sale of THC […]
Read More
Georgia poised to lift cultivation ban for limited medical cannabis program
Georgia lawmakers want to open the state to commercial medical marijuana cultivation, passing a bill that would offer fresh business opportunities in the Peach State’s limited MMJ program. The measure awaits the signature of Gov. Brian Kemp, who has indicated he supports offering in-state medical marijuana cultivation, according to The Atlanta Journal-Constitution. Georgia launched a limited MMJ program […]
Read More
Marijuana or hemp? Manufacturers snagged by Farm Bill confusion
Cannabis entrepreneurs say they’re facing jail time and hefty legal fees because of the plant’s complicated biology, with the vaunted 2018 Farm Bill only muddling the picture for interstate commerce. A pair of cases in Idaho and Oklahoma raised questions about how state and local law enforcement are supposed to tell the difference between hemp and marijuana. Since the […]
Read More
What is ‘marijuana’? Name game limits cannabis entrepreneurs
The old debate about what to call the plant cannabis sativa L. is giving businesses real-world headaches in both new and established marijuana markets. Consider: Iowa allows medical marijuana but calls it something else. Texas restricts medical marijuana so severely that doctors must break the law to use the state’s program. California officials are struggling […]
Read More
Iowa medical CBD sales set to begin Saturday under cloud of confusion
Iowa’s five CBD dispensaries open for business Saturday to serve roughly 1,000 patients in one of the nation’s most limited medical cannabis markets.
Read More
The pandemic pivot and how cannabis companies reacted to COVID-19.